AptaBio Therapeutics Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	3,441	3,361	323.87	48.35
Revenue Growth (YoY)	18.39%	937.76%	569.80%	-
Cost of Revenue	2,330	3,087	262.8	11.15
Gross Profit	1,111	273.69	61.06	37.21
Selling, General & Admin	5,067	3,893	3,385	2,788
Research & Development	12,046	14,591	12,380	6,197
Amortization of Goodwill & Intangibles	20.1	21.73	23.34	14.53
Other Operating Expenses	191.83	113.05	130.03	74.48
Operating Expenses	17,833	20,989	16,965	9,544
Operating Income	-16,722	-20,715	-16,904	-9,507
Interest Expense	-2,119	-3,401	-1,183	-4.49
Interest & Investment Income	1,585	2,296	1,984	1,572
Earnings From Equity Investments	813.25	-625.93	-4.19	-
Currency Exchange Gain (Loss)	-243.02	-252.8	-29.52	-14.43
Other Non Operating Income (Expenses)	-3,332	-4,651	1,688	42.49
EBT Excluding Unusual Items	-20,018	-27,350	-14,448	-7,911
Gain (Loss) on Sale of Investments	1,367	-452.59	-244.29	-2,654
Pretax Income	-18,652	-27,803	-14,692	-10,565
Income Tax Expense	1,575	1,575	-2,630	-
Net Income	-20,227	-29,378	-12,062	-10,565
Preferred Dividends & Other Adjustments	-	-	-195.14	-
Net Income to Common	-20,227	-29,378	-11,866	-10,565
Shares Outstanding (Basic)	25	24	22	22
Shares Outstanding (Diluted)	25	24	22	22
Shares Change (YoY)	4.22%	5.58%	0.05%	-
EPS (Basic)	-804.26	-1247.79	-532.16	-474.00
EPS (Diluted)	-804.26	-1247.79	-532.16	-474.00
Free Cash Flow	-15,669	-12,400	-15,440	-7,874
Free Cash Flow Per Share	-623.03	-526.67	-692.42	-353.27
Gross Margin	32.29%	8.14%	18.86%	76.95%
Operating Margin	-486.01%	-616.35%	-5219.25%	-19661.23%
Profit Margin	-587.86%	-874.09%	-3663.98%	-21849.26%
Free Cash Flow Margin	-455.40%	-368.94%	-4767.39%	-16284.04%
EBITDA	-16,213	-20,184	-16,364	-9,022
D&A For EBITDA	508.71	531.35	539.11	484.62
EBIT	-16,722	-20,715	-16,904	-9,507
Advertising Expenses	-	9	3	7.07

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.